PDE1 inhibitors: a review of the recent patent literature (2008-present)
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2022.2027910
Abstract: ABSTRACT Introduction PDE1 has been demonstrated to be a potential drug target for a variety of diseases, such as Alzheimer’s disease and cardiovascular disease. In the past decades, numerous PDE1 inhibitors with structural diversities have… read more here.
Keywords: pde1 inhibitors; pde1; inhibitors review; 2008 present ... See more keywords